ID NOW Influenza A+B 2.0 Testing Kit Influenza Nasal Swab Sample 24/Box

The ID NOW Influenza A+B 2.0 Testing Kit is used for the rapid detection of Influenza A and B viruses using nasal swab samples. This point-of-care diagnostic tool provides results within minutes, aiding in the quick identification and differentiation of flu strains. It is especially valuable in healthcare settings during flu season, enabling timely and appropriate antiviral treatment. Early detection helps manage infection spread and improves patient outcomes, making it an essential tool for clinicians in diagnosing and treating influenza.

The ID NOW Influenza A+B 2.0 Testing Kit is a rapid diagnostic tool designed to detect Influenza A and B viruses from nasal swab samples. Manufactured by Abbott, this advanced testing kit enables healthcare providers to quickly differentiate between the two types of influenza, supporting timely and accurate diagnosis. The kit is packaged with 24 tests per box, making it ideal for use in clinical settings such as hospitals, clinics, and urgent care facilities.

Details and Features:

• Rapid Results: The ID NOW platform delivers results in minutes, allowing for immediate decision-making in patient care.
  
• Ease of Use: Designed for user-friendly operation with minimal hands-on time, the kit is suitable for point-of-care testing environments.
  
• Sample Type: Utilizes nasal swab samples, providing a non-invasive method of specimen collection.
  
• Compact Design: The system is lightweight and portable, making it suitable for use in various healthcare settings, from emergency departments to outpatient clinics.
  
• Comprehensive Testing: Detects both Influenza A and B with a single test, improving efficiency in diagnosing influenza infections.
  
• Built-In Controls: Includes procedural controls within each test to ensure accuracy and reliability of results.

Mechanism of Action:

The ID NOW Influenza A+B 2.0 Testing Kit employs isothermal nucleic acid amplification technology to rapidly amplify and detect viral genetic material from influenza A and B viruses. This method provides high sensitivity and specificity, allowing for accurate differentiation between the two influenza types.

The ID NOW Influenza A+B 2.0 Testing Kit enhances influenza management in healthcare settings through its rapid result delivery, ease of use, and reliable technology. By facilitating immediate therapeutic decision-making, it plays a crucial role in infection control and patient care during flu seasons.